Clinical & Laboratory Haematology

The future for clinical scientists in laboratory medicine
pp. 197-204(8)
Authors: Hallworth, M.; Hyde, K.; Cumming, A.; Peake, I.

The erythrocyte adhesiveness/aggregation test for the detection of an acute phase response and for the assessment of its intensity
pp. 205-210(6)
Authors: Maharshak, N.; Shapira, I.; Rotstein, R.; Serov, J.; Aharonov, S.; Mardi, T.; Twig, A.; Rubinstein, A.; Kofler, M.; Berliner, S.; Zeltser, D.

Treatment of myelodysplasia with oral cyclosporin
pp. 211-214(4)
Authors: Atoyebi, W.; Bywater, L.; Rawlings, L.; Brunskill, S.; Littlewood, T.J.

HLA class I and class II antigens associated with multiple myeloma in southern Africa
pp. 215-219(5)
Authors: Patel, M.; Wadee, A.A.; Galpin, J.; Gavalakis, C.; Fourie, A.M.; Kuschke, R.H.; Philip, V.

Role of bone marrow examination in staging Hodgkin's disease: experience in México
pp. 221-223(3)
Authors: Gómez-Almaguer, D.; Ruiz-Argüelles, G.J.; López-MartÍnez, B.; Estrada, E.; Lobato-Mendiza´bal, E.; Jaime-Pérez, J.C.

The PFA-100^®: a potential rapid screening tool for the assessment of platelet dysfunction
pp. 225-232(8)
Authors: Harrison, P.; Robinson, M.; Liesner, R.; Khair, K.; Cohen, H.; Mackie, I.; Machin, S.

Human factor VII deficiency caused by S339C mutation located adjacent to the specificity pocket of the catalytic domain
pp. 233-238(6)
Authors: Takamiya, O.; Seta, M.; Tanaka, K.; Ishida, F.

Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts
pp. 239-242(4)
Authors: McNamara, C.; Juneja, S.; Wolf, M.; Grigg, A.

Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome
pp. 243-251(9)
Authors: Mazoyer, E.; Enjolras, O.; Laurian, C.; Houdart, E.; Drouet, L.

Patient self-management of oral anticoagulation
pp. 253-257(5)
Authors: Bhavnani, M.; Shiach, C.R.

Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine
pp. 259-260(2)
Authors: Tousi, B.; D'Silva, R.; Papish, S.

Not all cases of idiopathic thrombocytopenic pupura are what they might first seem
pp. 261-262(2)
Authors: Mainwaring, C.J.; Shutt, J.; James, C.M.

Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK
pp. 263-265(3)